Skip to main content
. 2023 Feb 2;9(2):e13423. doi: 10.1016/j.heliyon.2023.e13423

Table 1.

Demographic and clinical data of patients with CHD and HCs.

CHD (n = 26) HCs (n = 16) t/z/χ Effect size p value
Age (year) 60.46 ± 8.85 57.25 ± 10.48 1.064 0.338a 0.294c
Sex (male/female) 13/13 5/11 1.422 0.184b 0.233
BMI 24.25 ± 3.01 24.94 ± 3.93 −0.181 0.205a 0.856d
Hypertension classification (Normal/Grade I/II/III) 10/9/5/2 9/5/2/0 1.852 0.220b 0.699
Total cholesterol (mmol/L) 4.40 ± 1.12 3.86 ± 0.90 1.653 0.525a 0.106c
Triglycerides (mmol/L) 1.94 ± 1.14 1.49 ± 0.68 −0.933 0.449a 0.351d
Low-density lipoproteins (mmol/L) 2.62 ± 1.03 2.29 ± 0.91 1.063 0.338a 0.294c
Lipoprotein (a) (mg/L) 186.25 ± 200.35 245.08 ± 277.41 −0.195 0.253a 0.846d
Uric acid (umol/L) 335.69 ± 87.95 323.75 ± 95.27 0.414 0.132a 0.681c
Ejection fraction (%) 65.38 ± 4.06 65.38 ± 7.07 −1.040 0.002a 0.298d

The continuous variables are expressed as the mean ± standard deviation (Mean ± SD). BMI: body mass index; CHD: coronary heart disease; HCs: healthy controls. Effect size: Cohen's d (a) and η2 (b); Statistical analyses: independent-sample t-test (c) and Mann-Whitney test (d).